Last reviewed · How we verify
Experimental drug 9MW1911 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Experimental drug 9MW1911 (Experimental drug 9MW1911) — Mabwell (Shanghai) Bioscience Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Experimental drug 9MW1911 TARGET | Experimental drug 9MW1911 | Mabwell (Shanghai) Bioscience Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Experimental drug 9MW1911 CI watch — RSS
- Experimental drug 9MW1911 CI watch — Atom
- Experimental drug 9MW1911 CI watch — JSON
- Experimental drug 9MW1911 alone — RSS
Cite this brief
Drug Landscape (2026). Experimental drug 9MW1911 — Competitive Intelligence Brief. https://druglandscape.com/ci/experimental-drug-9mw1911. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab